Literature DB >> 2421248

Polymerase-defective mutant of the Bryan high-titer strain of Rous sarcoma virus.

M Sudol, T L Lerner, H Hanafusa.   

Abstract

A mutant of the Bryan high-titer strain of Rous sarcoma virus defective in reverse transcriptase is known as type alpha (BH-RSV alpha). BH-RSV alpha virion particles do not contain any polymerase-related proteins but they direct the synthesis of a normal sized Pr180 gag-pol polyprotein precursor in infected cells. Using a bioassay for polymerase gene function that is based on the requirement of viral replication for transformation of transfected chicken cells, we have localized the defect to the 2.5 kb EcoRI-KpnI DNA fragment containing more than 90% of the polymerase gene by comparison with the corresponding DNA fragment from the wild-type polymerase-positive BH-RSV, called type beta. In vitro recombination experiments with the polymerase gene of Schmidt-Ruppin RSV allowed us to map the defect to the 0.86 kb XbaI-BglII DNA fragment of the BH-RSV alpha polymerase. DNA sequence analysis of the entire polymerase gene of BH-RSV alpha and beta has revealed one point mutation that maps within that XbaI-BglII fragment and substitutes leucine in BH-RSV alpha for glutamine in the wild-type BH-RSV beta.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421248      PMCID: PMC339665          DOI: 10.1093/nar/14.5.2391

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Enhancement of virus yield of Rous sarcomas.

Authors:  W R BRYAN
Journal:  Acta Unio Int Contra Cancrum       Date:  1959

3.  RNA of replication-defective strains of Rous sarcoma virus.

Authors:  P H Duesberg; S Kawai; L H Wang; P K Vogt; H M Murphy; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

4.  Absence of polymerase protein in virions of alpha-type rous sarcoma virus.

Authors:  H Hanafusa; D Baltimore; D Smoler; K F Watson; A Yaniv; S Spiegelman
Journal:  Science       Date:  1972-09-29       Impact factor: 47.728

5.  A cell-associated factor essential for formation of an infectious form of Rous sarcoma virus.

Authors:  H Hanafusa; T Miyamoto; T Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

6.  Proteins of helper-dependent RSV.

Authors:  C M Scheele; H Hanafusa
Journal:  Virology       Date:  1971-08       Impact factor: 3.616

7.  Further studies on RSV production form transformed cells.

Authors:  H Hanafusa; T Hanafusa
Journal:  Virology       Date:  1968-04       Impact factor: 3.616

8.  Noninfectious RSV deficient in DNA polymerase.

Authors:  H Hanafusa; T Hanafusa
Journal:  Virology       Date:  1971-01       Impact factor: 3.616

9.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

10.  Quantitation of avian RNA tumor virus reverse transcriptase by radioimmunoassay.

Authors:  A Panet; D Baltimore; T Hanafusa
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

View more
  14 in total

1.  Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells.

Authors:  C J Petropoulos; S H Hughes
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants.

Authors:  J C Olsen; C Bova-Hill; D P Grandgenett; T P Quinn; J P Manfredi; R Swanstrom
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector.

Authors:  S Fuerstenberg; H Beug; M Introna; K Khazaie; A Muñoz; S Ness; K Nordström; J Sap; I Stanley; M Zenke
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  Genetic analysis of p60v-src domains involved in the induction of different cell transformation parameters.

Authors:  R Jove; B J Mayer; H Iba; D Laugier; F Poirier; G Calothy; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

5.  Construction and characterization of a replication-competent retroviral shuttle vector plasmid.

Authors:  Jangsuk Oh; John G Julias; Andrea L Ferris; Stephen H Hughes
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Appropriate in vivo expression of a muscle-specific promoter by using avian retroviral vectors for gene transfer [corrected].

Authors:  C J Petropoulos; W Payne; D W Salter; S H Hughes
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  Role of gag sequence in the biochemical properties and transforming activity of the avian sarcoma virus UR2-encoded gag-ros fusion protein.

Authors:  S M Jong; L H Wang
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.

Authors:  Michael S Mitchell; Ellen T Bodine; Shawn Hill; Gerald Princler; Patricia Lloyd; Hiroaki Mitsuya; Masao Matsuoka; David Derse
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  Host range mutants of v-src: alterations in kinase activity and substrate interactions.

Authors:  E C Liebl; L J England; J E DeClue; G S Martin
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not Rous sarcoma virus.

Authors:  R D Press; A Kim; D L Ewert; E P Reddy
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.